In short. Why a treatment made from the patient's own blood sits outside product approval, and exactly what that leaves unregulated.
Key points
- A device cleared to separate blood has been assessed for separating blood.
- A claim that the resulting preparation rejuvenates skin or restores hair has been assessed by nobody, and a description that runs the two together is borrowing a clearance for something it does not cover.
This treatment sits in a regulatory space that exists because the material is made at the point of care rather than supplied as a product. The shape of that space explains both the freedom and the uncertainty attached to it.
No product, no authorisation
An injectable that is manufactured is authorised as a product. Its composition is defined, its manufacture is inspected, its safety and performance are assessed for a named indication, and its labelling states what it is for. None of that structure can attach to a preparation made from one person’s blood in the same session in which it is injected. There is no batch, no release specification and no product to authorise, so there is no approved indication and no label.
The devices are regulated, and for something else
The centrifuge and the kits used with it are regulated as laboratory equipment. Their authorisation covers separating blood reliably and safely, which is a mechanical task. The gap that follows is precise: the equipment is assessed for what it does, and no authority has assessed the claim that what it produces is an effective cosmetic treatment. Both statements are true at once, and the second is routinely inferred from the first.
Approval of the equipment is not approval of the treatment
A device cleared to separate blood has been assessed for separating blood. A claim that the resulting preparation rejuvenates skin or restores hair has been assessed by nobody, and a description that runs the two together is borrowing a clearance for something it does not cover.
What is regulated instead
The practice of medicine around the treatment is regulated: who may perform it, what consent requires, how records are kept and how complications are handled. Guidance in several jurisdictions also addresses how such treatments may be advertised, precisely because the absence of a product approval leaves the claims unregulated at the point where they are made. That combination is worth understanding: the procedure is governed, the claim is not.
What follows for a person considering it
That the questions worth asking are about the process rather than the product, because there is no product. That a claim of approval should be followed by a question about what exactly was approved, since the preparation is not. And that because no external standard defines what should be in the syringe, the clinic’s own description of its method is the only specification available, which makes that description worth asking for.
Three questions about a regulatory claim
- What exactly is approved here — the device, the protocol, or the treatment?
- Is the material prepared and used in the same session, or supplied from elsewhere?
- Who is responsible for the preparation, and what standard is it held to?
None of this argues that the treatment is improper. It establishes what kind of oversight applies, which is the background against which everything else on this site should be read.
Frequently asked questions
Is PRP approved for any cosmetic use?
No. There is no cosmetic approval, and the reason is structural: authorisation attaches to a manufactured product with a defined composition, and a preparation made from the patient's own blood minutes before use is not one. There is therefore no approved indication and no label to read.
Are the kits and devices regulated?
They are regulated as laboratory equipment, and that authorisation covers separating blood reliably. It does not cover the claim that what comes out of the process is an effective cosmetic treatment, which is a clinical claim that no authority has assessed.
Does that mean the treatment is unregulated?
The practice of medicine around it is regulated, and the devices are regulated for what they do mechanically. What is not regulated is the claim, because there is no product to attach a claim to. That is why several authorities have issued guidance about how such treatments may be advertised.
Risks & Limitations
- There is no cosmetic approval, and no authority has assessed the claims made for the treatment.
- The platelet concentration depends on the kit, device and spin used, and is not standardised or comparable between clinics.
- Blood handled outside a controlled laboratory is a medium in which bacteria grow, so preparation carries a risk of infection that the source of the blood does not remove.
- The material is reabsorbed over a short period, so it does not restore volume the way a filler does.
- Adding it to another treatment is not evidence that the combination works better than the main treatment alone.
When to Seek Care
- Redness, warmth, swelling or pain that is increasing rather than settling after an injection.
- Discharge from an injection site, or a fever — seek prompt clinical assessment.
- An uneven or lumpy result, or any change in the treated area that concerns you.
- Contact the service that performed the treatment, or the hospital’s outpatient channels, rather than relying on a website.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — guidance on autologous cellular products and point-of-care preparation
- European Medicines Agency (EMA) and national regulators — guidance on blood-derived and autologous treatments
- National Medical Products Administration (NMPA, China) — regulation of blood-derived preparations and devices
- World Health Organization (WHO) — guidance on the safe preparation and handling of blood components
- Cochrane Library — systematic reviews of platelet-rich plasma for hair loss and skin indications
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.